Celldex Therapeutics Inc
CLDX
ISIN null / Valor 46207289
Celldex Therapeutics Inc
UMushroom community rating:
About company
Celldex Therapeutics, Inc. is a clinical-stage biopharmaceutical company that discovers and develops targeted biologic therapies — including monoclonal antibodies, antibody‑drug conjugates and immunomodulatory agents — with a primary focus on oncology and other serious diseases. The company advances programs through preclinical and clinical trials, aiming to demonstrate safety and efficacy to reach regulatory milestones, and routinely seeks partnerships or licensing arrangements to fund development and position programs for commercialization. As a small‑cap developer, Celldex's value proposition centers on progressing candidates to clinical proof‑of‑concept and creating deal value, while its outlook is governed by the usual sector risks of clinical, regulatory and financing uncertainty.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
1646 M
Market cap (USD)
359,603
Daily traded volume (Shares)
25.32 / 24.75
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
